Prelude Capital Management’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Prelude Capital Management’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-199,552	Closed	-$3.38M	–	2429
2014 Q4	$3.38M	Buy	+199,552	New	+$2.81M	0.5%	27
2014 Q3	–	Sell	-15,300	Closed	-$86K	–	2392
2014 Q2	$86K	Buy	15,300 +12,600	+467%	+$58.1K	0.01%	1157
2014 Q1	$10K	Sell	2,700 -14,800	-85%	-$56.4K	﹤0.01%	1762
2013 Q4	$59K	Hold	17,500	–	–	0.01%	1006
2013 Q3	$74K	Buy	+17,500	New	+$82.9K	0.01%	870

Prelude Capital Management's AVNR Position: Q1 2015 in Review

Prelude Capital Management sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 199,552 shares — an estimated $3.38M sold.

Prelude Capital Management first reported a position in AVNR in Q3 2013 and held it in 5 quarters. The position peaked at $3.38M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Prelude Capital Management reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Prelude Capital Management sold 199,552 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $3.38M.
Prelude Capital Management first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 5 quarters.
Prelude Capital Management's AVANIR PHARMACEUTICALS, INC CL A position peaked at $3.38M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Prelude Capital Management's 13F filing for Q1 2015, filed 15 May 2015.